BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Glaucarubinone

13,18-dehydroglaucarubinone [Supplementary Concept] structure

10+ PubMed studies analyzed · Evidence Score: 23.2

Research Domains

Glaucarubinone has been studied across 4 research domains including 🔬 Oncology, ⚡ Energy & Fatigue, ⏳ Longevity & Aging, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 60% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Glaucarubinone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

as
2 shared targets
rheum
2 shared targets
bletilla
2 shared targets
dimocarpus
2 shared targets
lycopus
2 shared targets
Rubia
2 shared targets
albizia
2 shared targets
anemarrhena
2 shared targets
cnidium
2 shared targets
scolopendra
2 shared targets
Loading evidence profile...

This evidence profile for Glaucarubinone is generated deterministically from 10 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.